SKI Market

A+| A| A-|

Indian Indices

Sensex

76,226.43 811.08
( 1.08%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

36.3585943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

15.45

30.9

EPS(TTM)

Face Value()

Div & Yield %

2.33

Back

Aryaman Capital Markets standalone net profit declines 50.43% in the December 2025 quarter

Feb 13,2026

Net profit of Aryaman Capital Markets declined 50.43% to Rs 5.73 crore in the quarter ended December 2025 as against Rs 11.56 crore during the previous quarter ended December 2024. Sales declined 35.13% to Rs 15.44 crore in the quarter ended December 2025 as against Rs 23.80 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15.44	23.80	-35
OPM %	45.21	58.49	-
PBDT	7.65	13.80	-45
PBT	7.61	13.77	-45
NP	5.73	11.56	-50

76,226.43 811.08 ( 1.08%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

65,182.04 1,842.97 (2.91%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)